Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
MDGL
#778
Madrigal Pharmaceuticals, Inc. Common Stock
432.000
0
-0.54%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.54%
Variazione Mensile
-14.35%
Variazione di 6 mesi
+1.98%
Variazione Annuale
+1.98%
Chiusura Precedente
434.360
0
Open
432.000
0
Bid
Ask
Low
432.000
0
High
432.000
0
Volume
139
Mercati
Mercato Azionario Statunitense
Salute
MDGL
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
16.02 M
17.1 M
18.14 M
19.9 M
22.08 M
22.94 M
—
Valuation ratios
Enterprise value
1.73 B
1.41 B
4.85 B
4.41 B
6.71 B
13.16 B
37.01 B
Price to earnings ratio
—
—
-16.57
-11.35
-14.09
-45.32
-123.66
Price to sales ratio
—
—
—
—
36.44
13.63
62.89
Price to cash flow ratio
—
—
21.75
13.08
14.41
68.92
169.55
Price to book ratio
—
—
24.78
10.46
8.7
21.68
29.85
Enterprise value to EBITDA ratio
—
—
—
—
-13.51
—
—
Profitability ratios
Return on assets %
0.7
0.88
0.81
0.58
0.45
0.23
0.25
Return on equity %
0.84
1.23
1.5
0.92
0.62
0.48
0.44
Return on invested capital %
38.24 K
46.1 K
60.8 K
54.38 K
28.26 K
9 549.63
—
Gross margin %
—
—
—
—
96.54
100
396.71
Operating margin %
—
—
—
—
276.39
31.31
138.21
EBITDA margin %
—
—
—
—
-275.78
—
—
Net margin %
—
—
—
—
258.64
30.08
131.22
Liquidity ratios
Quick ratio
—
—
—
—
5.9
3.77
17.4
Current ratio
6.13
3.54
3.12
5.38
6.1
4.01
18.47
Inventory turnover
—
—
—
—
0.18
—
—
Asset turnover
0
0
0
0
0.21
0.83
0.83
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.14
0.18
0.11
0.27
0.75
Long term debt to total equity ratio
—
—
0.25
0.28
0.16
0.56
1.44
Per share metrics
Operating cash flow per share
—
—
13.12
17.35
21.42
8.45
8.54
EBIT per share
—
—
—
—
-23.4
—
—
EBITDA per share
—
—
—
—
-23.35
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
20.94
33.93
43.78
43.84
167.93
Net current asset value per share
—
—
21.09
34.1
48.56
55.53
205.33
Tangible book value per share
—
—
11.52
21.69
35.24
26.54
117.13
Working capital per share
—
—
14.32
27.76
40.6
41.7
157.67
Book value per share
—
—
11.52
21.69
35.46
26.86
118.21
Notizie
Madrigal: The Easiest Money May Have Been Made (NASDAQ:MDGL)
Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)
H.C. Wainwright conferma il rating Buy su Madrigal Pharmaceuticals
H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Lam Research, Goldman Sachs among market cap stock movers on Thursday
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript
Oracle, Deere among market cap stock movers on Thursday
Madrigal Q4 2025 slides: Rezdiffra nears $1B in first year sales despite EPS miss
Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates
Le azioni Madrigal Pharma calano oltre il 5% per utili Q4 deludenti
Madrigal Pharma shares fall over 5% as Q4 earnings miss overshadows revenue beat